These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35887801)

  • 1. An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava.
    Soares RB; Dinis-Oliveira RJ; Oliveira NG
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of carboxylesterase 1 by Kava (Piper methysticum) Kavalactones.
    Melchert PW; Qian Y; Zhang Q; Klee BO; Xing C; Markowitz JS
    Chem Biol Interact; 2022 Apr; 357():109883. PubMed ID: 35278473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effects of Kava (Piper Methysticum) constituents in cancers: A systematic review.
    Celentano A; Tran A; Testa C; Thayanantha K; Tan-Orders W; Tan S; Syamal M; McCullough MJ; Yap T
    J Oral Pathol Med; 2019 Aug; 48(7):510-529. PubMed ID: 31172600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kava and its Kavalactones Inhibit Norepinephrine-induced Intracellular Calcium Influx in Lung Cancer Cells.
    Botello JF; Corral P; Bian T; Xing C
    Planta Med; 2020 Jan; 86(1):26-31. PubMed ID: 31711251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biosynthetic origin of psychoactive kavalactones in kava.
    Pluskal T; Torrens-Spence MP; Fallon TR; De Abreu A; Shi CH; Weng JK
    Nat Plants; 2019 Aug; 5(8):867-878. PubMed ID: 31332312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Different Forms of Kava (Piper methysticum) Products by UPLC-MS/MS.
    Mamallapalli J; Kanumuri SRR; Corral P; Johnston E; Zhuang C; McCurdy CR; Mathews CA; Sharma A; Xing C
    Planta Med; 2022 Nov; 88(14):1348-1359. PubMed ID: 34839465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
    Thomsen M; Schmidt M
    J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
    Anke J; Ramzan I
    J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence.
    Teschke R; Qiu SX; Xuan TD; Lebot V
    Phytother Res; 2011 Sep; 25(9):1263-74. PubMed ID: 21442674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of kava in the treatment of anxiety disorders.
    Singh YN; Singh NN
    CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of kavalactones in dried kava (Piper methysticum) powder using near-infrared reflectance spectroscopy and partial least-squares regression.
    Gautz LD; Kaufusi P; Jackson MC; Bittenbender HC; Tang CS
    J Agric Food Chem; 2006 Aug; 54(17):6147-52. PubMed ID: 16910700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Lab Validation for Determination of Kavalactones and Flavokavains in Piper methysticum (Kava).
    Liu Y; Lund JA; Murch SJ; Brown PN
    Planta Med; 2018 Nov; 84(16):1213-1218. PubMed ID: 29940660
    [No Abstract]   [Full Text] [Related]  

  • 14. DARK Classics in Chemical Neuroscience: Kava.
    Volgin A; Yang L; Amstislavskaya T; Demin K; Wang D; Yan D; Wang J; Wang M; Alpyshov E; Hu G; Serikuly N; Shevyrin V; Wappler-Guzzetta E; de Abreu M; Kalueff A
    ACS Chem Neurosci; 2020 Jan; ():. PubMed ID: 31904216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats.
    Yamazaki Y; Hashida H; Arita A; Hamaguchi K; Shimura F
    Food Chem Toxicol; 2008 Dec; 46(12):3732-8. PubMed ID: 18930106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kava-kava and anxiety: growing knowledge about the efficacy and safety.
    Bilia AR; Gallon S; Vincieri FF
    Life Sci; 2002 Apr; 70(22):2581-97. PubMed ID: 12269386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and in vitro toxicity analysis of a supercritical fluid extract of Kava kava (Piper methysticum).
    Petersen GE; Tang Y; Fields C
    J Ethnopharmacol; 2019 May; 235():301-308. PubMed ID: 30710733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2012 Mar; (571):1-186. PubMed ID: 22441424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal for a kava quality standardization code.
    Teschke R; Lebot V
    Food Chem Toxicol; 2011 Oct; 49(10):2503-16. PubMed ID: 21756963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents.
    Wang J; Qu W; Bittenbender HC; Li QX
    J Food Sci Technol; 2015 Feb; 52(2):1164-9. PubMed ID: 25694734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.